{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:21:04Z","timestamp":1789593664593,"version":"build-2803163510"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.1001\/jamadermatol.2020.5595","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T11:31:28Z","timestamp":1612611088000},"page":"301","source":"Crossref","is-referenced-by-count":37,"title":["Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)"],"prefix":"10.1001","volume":"157","author":[{"given":"Alexa B.","family":"Kimball","sequence":"first","affiliation":[{"name":"Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"Guenther","sequence":"additional","affiliation":[{"name":"The Guenther Dermatology Research Centre, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kalia","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke M. G. J.","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly Parnell","family":"Lafferty","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Y.","family":"Chen","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Langholff","sequence":"additional","affiliation":[{"name":"Janssen Research and Development, LLC, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"doi200077r1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States.","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi200077r2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijwd.2019.04.021","article-title":"Clinical considerations for the management of psoriasis in women.","volume":"5","author":"Gottlieb","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"doi200077r3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/jid.2011.271","article-title":"The impact of psoriasis on pregnancy outcomes.","volume":"132","author":"Lima","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"2","key":"doi200077r4","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.jaad.2009.05.004","article-title":"Pregnancy outcomes in psoriasis: why do we know so little?","volume":"61","author":"Horn","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"doi200077r5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2340\/00015555-2923","article-title":"Effect of maternal psoriasis on pregnancy and birth outcomes: a population-based cohort study from Denmark and Sweden.","volume":"98","author":"Br\u00f6ms","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"doi200077r6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.14547","article-title":"Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies.","volume":"175","author":"Bobotsis","year":"2016","journal-title":"Br J Dermatol"},{"issue":"9","key":"doi200077r7","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/art.40508","article-title":"Pregnancy outcomes after exposure to certolizumab pegol: updated results from a pharmacovigilance safety database.","volume":"70","author":"Clowse","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"doi200077r8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijwd.2016.12.003","article-title":"Update on biologic safety for patients with psoriasis during pregnancy.","volume":"3","author":"Porter","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"doi200077r9","first-page":"56","article-title":"A comprehensive survey assessing the family planning needs of women with psoriasis.","volume":"98","author":"Lebwohl","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"doi200077r10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/bjd.2014.171.issue-1","article-title":"Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR).","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"key":"doi200077r11","doi-asserted-by":"crossref","first-page":"AB179","DOI":"10.1016\/j.jaad.2014.01.742","article-title":"Pregnancy outcomes in women with moderate to severe psoriasis: the PSOLAR experience.","volume":"70","author":"Kimball","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"346","key":"doi200077r12","first-page":"1","article-title":"Births in the United States, 2018.","author":"Martin","year":"2019","journal-title":"NCHS Data Brief"},{"issue":"5","key":"doi200077r14","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1097\/AOG.0000000000002899","article-title":"ACOG Practice Bulletin No. 200: early pregnancy loss.","volume":"132","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"11","key":"doi200077r16","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1097\/MIB.0000000000001234","article-title":"Anti\u2013TNF-a use during the third trimester of pregnancy in women with moderate-severe inflammatory bowel disease and the risk of preterm birth and low birth weight.","volume":"23","author":"Kammerlander","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"doi200077r17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/bcp.12642","article-title":"Pregnancy outcome after TNF-a inhibitor therapy during the first trimester: a prospective multicentre cohort study.","volume":"80","author":"Weber-Schoendorfer","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"doi200077r18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/09546634.2018.1468066","article-title":"Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab.","volume":"30","author":"Galluzzo","year":"2019","journal-title":"J Dermatolog Treat"},{"issue":"10","key":"doi200077r19","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1111\/jdv.v33.10","article-title":"Psoriasis and pregnancy outcomes in biological therapies: a real-life, multi-centre experience.","volume":"33","author":"Odorici","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"doi200077r20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/ijms19051349","article-title":"The use and safety of TNF inhibitors during pregnancy in women with psoriasis: a review.","volume":"19","author":"Johansen","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5","key":"doi200077r21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/bjd.16901","article-title":"Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database.","volume":"179","author":"Warren","year":"2018","journal-title":"Br J Dermatol"},{"key":"doi200077r13","unstructured":"Centers for Disease Control and Prevention. Data & statistics on birth defects. Reviewed January 23, 2020. Accessed September 18, 2020. https:\/\/www.cdc.gov\/ncbddd\/birthdefects\/data.html"},{"key":"doi200077r15","unstructured":"Centers for Disease Control and Prevention. Preterm birth. Reviewed October 21, 2019. Accessed September 18, 2020. https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/pretermbirth.htm"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2775503\/jamadermatology_kimball_2021_oi_200077_1615934617.50165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T15:01:54Z","timestamp":1615993314000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2775503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.5595","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}